Indian Patent Office Rejects Sprycel Compulsory License Application
This article was originally published in PharmAsia News
Executive Summary
Lack of sufficient grounds to apply for a compulsory license for Sprycel dashed hopes for BDR Pharma, but the fight may not be over just yet.